PMID(sorted ascending)
drug susceptibility testing and pharmacokinetics question current treatment regimens in mycobacterium simiae complex disease.the mycobacterium simiae complex bacteria can cause opportunistic infections in humans. in the case of definite disease, there are no evidence-based treatment regimens and outcomes are very disappointing. to increase the evidence base underpinning treatment regimens for m. simiae complex disease, drug susceptibility patterns and rifampicin/ethambutol synergy were assessed retrospectively in 69 clinical m. simiae complex isolates from 60 patients (22 patients with m. simiae, 24 with mycobacterium ...201122099521
Displaying items 1 - 1 of 1